We are live on ! Find out more
ALNY icon

Alnylam Pharmaceuticals
ALNY

593 hedge funds and large institutions have $30.1B invested in Alnylam Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 98 funds opening new positions, 239 increasing their positions, 180 reducing their positions, and 62 closing their positions.

New
Increased
Maintained
Reduced
Closed

58% more first-time investments, than exits

New positions opened: 98 | Existing positions closed: 62

33% more repeat investments, than reductions

Existing positions increased: 239 | Existing positions reduced: 180

17% more call options, than puts

Call options by funds: $195M | Put options by funds: $166M

5% more funds holding

Funds holding: 566 → 593 (+27)

2.61% more ownership

Funds ownership: 96.47% → 99.08% (+2.6%)

12% less capital invested

Capital invested by funds: $34.1B → $30.1B (-$3.99B)

43% less funds holding in top 10

Funds holding in top 10: 7 → 4 (-3)

Holders
593
Holders Change
+27
Holders Change %
+4.77%
% of All Funds
7.81%
Holding in Top 10
4
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-42.86%
% of All Funds
0.05%
New
98
Increased
239
Reduced
180
Closed
62
Calls
$195M
Puts
$166M
Net Calls
+$29M
Net Calls Change
-$10.2M

Top Buyers

1
Capital Research Global Investors
Capital Research Global Investors
California
+$454M
2
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
+$327M
3
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$87.6M
4
Marshall Wace
Marshall Wace
United Kingdom
+$82.9M
5
AQR Capital Management
AQR Capital Management
Connecticut
+$80.9M

Top Sellers

1
Capital International Investors
Capital International Investors
California
-$671M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$312M
3
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
-$223M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$199M
5
Pictet Asset Management
Pictet Asset Management
Switzerland
-$61.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
EWA
476
EverSource Wealth Advisors
Alabama
$97.9K +$24.5K +93 +29%
BF
477
BOK Financial
Oklahoma
$90.7K +$85.7K +326 +593%
VSQM
478
V-Square Quantitative Management
Illinois
$87.1K +$3.68K +14 +4%
PWMG
479
Prestige Wealth Management Group
New Jersey
$74.4K -$35.5K -135 -30%
EDRH
480
Edmond de Rothschild Holding
Switzerland
$63.3K +$70.7K +269 New
BC
481
Bayforest Capital
United Kingdom
$62.8K +$70.2K +267 New
Jones Financial Companies
482
Jones Financial Companies
Missouri
$62.6K +$70K +266 New
VWM
483
Venturi Wealth Management
Texas
$59.3K +$65.2K +248 +6,200%
HPC
484
HM Payson & Co
Maine
$59.3K +$66.3K +252 New
EPIM
485
Evelyn Partners Investment Management
$58.8K +$65.7K +250 New
QCG
486
Quadrant Capital Group
Ohio
$57.9K -$1.31K -5 -2%
FFA
487
Farther Finance Advisors
California
$56.8K +$7.89K +30 +14%
IA
488
IFP Advisors
Florida
$56.7K +$12.4K +47 +24%
SWM
489
Spire Wealth Management
Virginia
$48.3K -$46K -175 -46%
AIM
490
Anchor Investment Management
South Carolina
$47.1K – – –
CWP
491
Concord Wealth Partners
Virginia
$47.1K – – –
CFG
492
CKW Financial Group
Hawaii
$47K – – –
VCM
493
Versant Capital Management
Arizona
$44.7K +$21.8K +83 +78%
IUHSA
494
Itau Unibanco Holding S.A.
Brazil
$40.2K -$36K -137 -44%
CAL
495
Capital Advisors Ltd
Ohio
$38K – – –
TWD
496
True Wealth Design
Ohio
$35.8K -$526 -2 -1%
CAS
497
Coppell Advisory Solutions
Texas
$35.4K +$2.89K +11 +8%
CT
498
Colonial Trust
South Carolina
$35.3K +$39.4K +150 New
OIAM
499
OFI Invest Asset Management
France
$35.2K +$40.8K +155 New
CWC
500
Carolinas Wealth Consulting
North Carolina
$35.1K -$2.63K -10 -6%
18 19
20
21 22

ALNY Hedge Fund Activity: Q4 2024 in Review

593 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Alnylam Pharmaceuticals (ALNY) for Q4 2024, worth a combined $30.1B — down 12% from $34.1B a quarter earlier.

Buyers outnumbered sellers: 98 funds opened new ALNY positions and 62 closed out — a net gain of 36 holders — while 239 added to existing stakes and 180 trimmed.

The largest buyer was Capital Research Global Investors, adding an estimated $454M. The largest seller was Capital International Investors, cutting an estimated $671M.

  • 593 institutional investors held Alnylam Pharmaceuticals (ALNY) as of Q4 2024, up from 566 in Q3 2024.
  • Funds reported $30.1B of Alnylam Pharmaceuticals stock for Q4 2024, down 12% quarter-over-quarter.
  • 98 funds opened new Alnylam Pharmaceuticals positions in Q4 2024 and 62 closed out, a net change of +36 holders.
  • The largest Alnylam Pharmaceuticals buyer in Q4 2024 was Capital Research Global Investors, an estimated $454M added.
  • The largest Alnylam Pharmaceuticals seller in Q4 2024 was Capital International Investors, an estimated $671M sold.

Based on aggregated 13F filings for Q4 2024.